跳至主要内容
临床试验/NCT00966199
NCT00966199Unknown4 期

Medication Induced Blood Pressure Reduction; Assessment of Cerebral Perfusion and Cognition in Hypertensive Elderly

Radboud University Medical Center1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
60
试验地点
1
主要终点
Cerebral blood flow

研究概览

简要总结

The purpose of this study is to determine if a reduction in systolic blood pressure induced by anti-hypertensive medication results in changes in cerebral perfusion and cognition in hypertensive elderly. Hypertensive elderly will be treated using open-label anti-hypertensive medication for 8-12 weeks. Changes in cerebral perfusion and cognition will be assessed before and after treatment.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >= 70 years
  • Systolic office blood pressure >= 160 mmHg
  • Systolic home blood pressure >= 155 mmHg

排除标准

  • Diabetes Mellitus
  • Atrial fibrillation
  • Renal failure requiring dialysis
  • Life expectancy of less than 1 year
  • Disabling stroke
  • Contraindication for MRI or anti-hypertensive medication
  • Systolic blood pressure > 220 mmHg

研究组 & 干预措施

Hypertensive elderly

Experimental

community dwelling hypertensive elderly from general practices

干预措施: anti-hypertensive medication (Drug)

结局指标

主要结局

Cerebral blood flow

时间窗: T1, 8-12 weeks of treatment, T2

次要结局

  • Cognitive functioning assessed by neuropsychological testing(T1, 8-12 weeks of treatment, T2-3)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验